JNJ

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Johnson & Johnson

At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 130 years, we have aimed to keep people well at every age and every stage of life. Today, as the world’s largest and most broadly-based healthcare company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. We are blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity.
CEO
Alex Gorsky
Employees
134500
Headquarters

1 Johnson And Johnson Plz
New Brunswick, New Jersey 08933-0001
Phone: 17325242455
www.jnj.com

News

3 Dividend Stocks That Are Too Good to Ignore: Q1 Edition
Feb 26, 2024 17:53pm

Dividend stocks are an ideal way to build wealth. Whether you are just starting your investment journey or looking for ways to enjoy steady returns on your investment, investing in dividend stocks is a smart move. There are several dividend-paying companies in the industry, but not every company will reward you equally. You must look beyond the dividend yield and pick stocks that show long-term growth and can sustain the dividends. The right stocks will not only offer a chance to grow your money but will also help build a passive income stream. Look for profitable companies with a solid history of dividend increases and steady cash flow generation. Here are my picks of the three dividend stocks too good to ignore this quarter. Dividend Stocks to Buy: Chevron (CVX) Source: Jeff Whyte / Shutterstock.com The tight monetary policy has had a strong impact on oil prices, and I think this is a smart opportunity to load up on Chevron (NYSE: CVX ). Warren Buffett’s favorite stock, CVX is down 5% in the past year and is trading for $154 today.


Source:InvestorPlace
Clear shift in skincare market as Gen Z moves away from fairness products
Feb 25, 2024 17:49pm

Fairness creams declined 3% in 2023, signaling a shift towards brightening, glow, radiance, and anti-dullness products. Hindustan Unilever Ltd (HUL) renamed its fairness cream Glow & Lovely to distance from racial injustice protests. L''Oreal and Johnson & Johnson also dropped ''white'' and ''fair'' from their skincare range. The overall skincare industry in India grew 9.2% in 2023.


Source:Economic Times India
Pension Plan Redux: 3 Companies That Could Take a Page From IBM’s Playbook
Feb 24, 2024 13:30pm

Earlier in February, The New York Times reported on changes IBM (NYSE: IBM ) has made to its pension plans that will likely save it millions in payments to its employees. This was the first time I’d read anything about the move. However, new stories about the subject started popping up as early as Nov. 7. Russell Investments published How IBM reopened its DB plan to replace 401(k) contributions on its company website: “Starting in 2024, IBM will replace its 401(k) plan matching contributions with a new benefit earned within its overfunded DB plan, which has been frozen since 2008. This move essentially un-freezes the tech giant’s DB plan,” Russell Investments’ Justin Owens wrote in November. While Owens suggests that the new benefit will likely be of similar value, others believe IBM did this to avoid millions in payments to its employees. Here’s what NYT Strategies columnist Jeff Sommer had to say about the move: “Crucially, IBM’s maneuver is likely to be wonderful for its shareholders.


Source:InvestorPlace
3 Stocks to Buy That Are Up 200% or More in 2024
Feb 23, 2024 19:19pm

With stocks up 200%, you face a dilemma. While you don’t want to fight momentum, you also don’t want to buy into excessive exuberance and jump into a stock at its top, forced to hold until break-even or sell for a loss down the road. These three companies represent solid picks among the handful of stocks up 200% in 2024. One has a long and fruitful future, buffeted by ongoing enthusiasm for machine learning and advanced computing. The other two represent equity arbitrage plays, and while they may not be 10x stocks any longer, they still offer some upside to investors waiting for an M&A deal to close. Super Micro Computer Inc (SMCI) Source: rafapress / Shutterstock.com Super Micro Computer (NASDAQ: SMCI ) tops the list of 2024 stocks up 200% as shares surged 240% since January. Last week, shares took a quick dip, falling about 26% before climbing up to just below $1,000 per share. The “flash crash” shook loose some paper-handed retail traders betting on SMCI’s prospects as a meme stock, but the company’s 2024 potential doesn’t end there.


Source:InvestorPlace
Evaluating Johnson & Johnson Against Peers In Pharmaceuticals Industry
Feb 23, 2024 16:00pm

In today''s fast-paced and highly competitive business world, it is crucial for investors and industry followers to conduct comprehensive company evaluations. In this article, we will delve into an extensive industry comparison, evaluating Johnson & Johnson (NYSE: JNJ ) in relation to its major competitors in the Pharmaceuticals industry. By closely examining key financial metrics, market standing, and growth prospects, our objective is to provide valuable insights and highlight company''s performance in the industry. Johnson & Johnson Background Johnson & Johnson is the world''s largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas.


Source:Benzinga